Form 4 for RLMD RELMADA THERAPEUTICS, INC.
Accepted 2021-09-24 00:00:00 ET · period of report 2021-09-22 · accession 0001213900-21-049820 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-24 | 2021-09-22 | RLMD | CASAMENTO CHARLES J | Dir | S - Sale+OE | $29.00 | -6,600 | 14.7K | -31% | -$191.4K |
| D | 2021-09-24 | 2021-09-22 | RLMD | CASAMENTO CHARLES J | Dir | M - OptEx | $4.60 | +10.0K | 16.6K | +152% | +$46.0K |
| D | 2021-09-24 | 2021-09-22 | RLMD | CASAMENTO CHARLES J | Dir | M - OptEx | $0.00 | -1,900 | 97.3K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-22 | S | D | 1,400 | $29.00 | 10,000 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-22 | S | D | 3,300 | $29.00 | 11,400 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-22 | S | D | 1,900 | $29.00 | 14,700 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-22 | M | A | 10,000 | $4.60 | 16,600 | D | — | — | |
| 5 | Derivative | Options to purchase common stock | 2021-09-22 | M | D | 1,900 | $0.00 | 97,311 | D | $3.24 · 2017-10-20 to 2027-10-20 | 1,900 Common Stock | (F3) Not applicable (F2) The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period.. |